Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mackay

Showing results (1-10 of 336) with videos related to

Pageof 34
Sort By:
Developments in Biologicals|December 16, 2004
Vaccines for minor use/minor species (MUMS) in the European unionD Mackay
Trends in Pharmacological Sciences|January 1, 1990
Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex modelsD Mackay
British Journal of Hospital Medicine|March 1, 1982
Cognitive behaviour therapyD Mackay
Trends in Pharmacological Sciences|May 1, 1991
Receptor classification using antagonistsD Mackay
Developments in Biologicals|March 4, 2005
Harmonising testing requirements for FMD vaccinesD Mackay
The Journal of Pharmacy and Pharmacology|May 1, 1978
How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?D MacKay
Trends in Pharmacological Sciences|March 1, 1990
Alternative version of steady-state ternary-complex model. Agonist potency, affinity and efficacyD Mackay
British Medical Journal|November 11, 2010
Delayed healing of a vesicovaginal fistula by inflammatory reactionD MACKAY
British Journal of Pharmacology|May 1, 1981
An analysis of functional antagonism and synergismD Mackay
Trends in Pharmacological Sciences|April 1, 1988
A generally useful modification of ALLFIT that facilitates the fitting of null equations to dose-response curvesD Mackay
Pageof 34

Showing results (1-10 of 336) with videos related to

Sort By:
Pageof 34
Developments in Biologicals|December 16, 2004
Vaccines for minor use/minor species (MUMS) in the European unionD Mackay
Trends in Pharmacological Sciences|January 1, 1990
Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex modelsD Mackay
British Journal of Hospital Medicine|March 1, 1982
Cognitive behaviour therapyD Mackay
Trends in Pharmacological Sciences|May 1, 1991
Receptor classification using antagonistsD Mackay
Developments in Biologicals|March 4, 2005
Harmonising testing requirements for FMD vaccinesD Mackay
The Journal of Pharmacy and Pharmacology|May 1, 1978
How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?D MacKay
Trends in Pharmacological Sciences|March 1, 1990
Alternative version of steady-state ternary-complex model. Agonist potency, affinity and efficacyD Mackay
British Medical Journal|November 11, 2010
Delayed healing of a vesicovaginal fistula by inflammatory reactionD MACKAY
British Journal of Pharmacology|May 1, 1981
An analysis of functional antagonism and synergismD Mackay
Trends in Pharmacological Sciences|April 1, 1988
A generally useful modification of ALLFIT that facilitates the fitting of null equations to dose-response curvesD Mackay
Pageof 34